SPECIAL NOTICE
Q -- Notice of Intent to Sole Souce- Decipher Genomic Prostate Cancer Testing (NTX)
- Notice Date
- 6/1/2021 8:26:37 AM
- Notice Type
- Special Notice
- NAICS
- 621511
— Medical Laboratories
- Contracting Office
- 257-NETWORK CONTRACT OFFICE 17 (36C257) ARLINGTON TX 76006 USA
- ZIP Code
- 76006
- Solicitation Number
- 36C25721Q0886
- Response Due
- 6/8/2021 1:00:00 PM
- Archive Date
- 06/23/2021
- Small Business Set-Aside
- 8AN 8(a) Sole Source (FAR 19.8)
- Description
- Special Notice � Notice of Intent to Award a Sole Source Procurement The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a firm-fixed priced contract (Period of Performance: 12 Months) to Decipher Corp. for the procurement of Decipher Genomic Prostate Cancer Testing. The testing will include: all related CPT codes, all labor, supplies, equipment, insurance, and supervision to provide the items. �The off-site testing will be administered by the VA North Texas Healthcare System, Pathology & Laboratory Medicine Service, 4500 S. Lancaster Rd., Dallas, TX 75216.���� Item Description 0001 Provide send out reference laboratory testing not performed in-house at VANTHCS Pathology & Laboratory Medicine Service Lab. Test will encompass all CPT codes. Contractor will provide all labor, supplies, equipment, insurance, and supervision to provide the items. Items are to be ordered on an as needed basis exact quantities of each item cannot be determined in advance as they are based upon physician's orders.� Decipher Assay Estimated QTY: 10 tests/month The proposed sole source procurement will be made by a pricing agreement with Decipher Corp., based upon pricing from previous contracts.��������� The requesting activity states the off-site testing agreement is for genomic prostate cancer testing; required for the testing of post-surgery oncology patients. The sole source justification request submitted by the requesting activity stated that a sole source is required because they require genomic prostate cancer testing for patients who have previously undergone surgery to determine the likelihood of the cancer reoccurrence.� This notice is not to be considered a request for quotations or proposals. A contract will not be awarded based on an offer received in response to this notice; however, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.� Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government.� If no affirmative written response is received within five (5) days from the publication of this notice, a contract will be issued to Decipher Corp., without any further notice. The anticipated statutory authority permitting other than full and open competition for the requirement is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services will Satisfy Agency Needs.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/ca65291867404fefaea2423f469273b6/view)
- Place of Performance
- Address: Dallas, TX 75216, USA
- Zip Code: 75216
- Country: USA
- Zip Code: 75216
- Record
- SN06017461-F 20210603/210601230113 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |